Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 1 |
2024 | 2 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Targetable leukaemia dependency on noncanonical PI3Kγ signalling.
Nature. 2024 May 8. doi: 10.1038/s41586-024-07410-3. Online ahead of print.
Nature. 2024.
PMID: 38720074
Phase 1b trial of tagraxofusp in combination with azacitidine with or without venetoclax in acute myeloid leukemia.
Lane AA, Garcia JS, Raulston EG, Garzon JL, Galinsky I, Baxter EW, Leonard R, DeAngelo DJ, Luskin MR, Reilly CR, Stahl M, Stone RM, Vedula RS, Wadleigh MM, Winer ES, Mughal T, Brooks C, Gupta IV, Stevenson KE, Neuberg DS, Ren S, Keating J, Konopleva M, Stein A, Pemmaraju N.
Lane AA, et al. Among authors: raulston eg.
Blood Adv. 2024 Feb 13;8(3):591-602. doi: 10.1182/bloodadvances.2023011721.
Blood Adv. 2024.
PMID: 38052038
Free PMC article.
Clinical Trial.
Item in Clipboard
Targetable leukemia dependency on noncanonical PI3Kγ signaling.
Luo Q, Raulston EG, Prado MA, Wu X, Gritsman K, Yan K, Booth CAG, Xu R, van Galen P, Doench JG, Shimony S, Long HW, Neuberg DS, Paulo JA, Lane AA.
Luo Q, et al. Among authors: raulston eg.
bioRxiv [Preprint]. 2023 Dec 15:2023.12.15.571909. doi: 10.1101/2023.12.15.571909.
bioRxiv. 2023.
PMID: 38328043
Free PMC article.
Updated.
Preprint.
Item in Clipboard
Cite
Cite